Effect of simvastatin treatment on rat livers subjected to ischemia/reperfusion

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 757-762

  Trocha, Małgorzata ^a   Merwid Lad, Anna ^a   Chlebda, Ewa ^a   Pieśniewska, Małgorzata ^a   Sozański, Tomasz ^a   Szelag, Adam ^a  

^a Wroclaw Medicial University   (Poland)

Author keywords

Ischemia reperfusion; Oxidative stress; Rat; Simvastatin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; SIMVASTATIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIVER HOMOGENATE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; REPERFUSION INJURY; TREATMENT DURATION;

EID: 77957991647     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70335-2     Document Type: Article

References (30)

1. Arduini A, Mezzetti A, Porreca E, Lapenna D, DeJulia J, Marzio L, Polidoro G et al.: Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. Biochim Biophys Acta, 1988, 970, 113-121.
2. Carneado J, Alvarez de Sotomayor M, Perez-Guerrero C, Jimenez L, Herrera MD, Pamies E, Martin-Sanz MD et al.: Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect. J Hypertens, 2002, 20, 429-437.
3. Ceylan A, Karasu C, Aktan F, Güven C, Can B, Ozansoy G: Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of diabetic rat myocardium. Gen Physiol Biophys, 2003, 22, 535-547.
4. Cobreros A, Sainz L, Lasheras B, Cenarruzabeitia E: Hepatotoxicity of ethanol: protective effect of calcium channel blockers in isolated hepatocytes. Liver, 1997, 17, 76-82.
5. Fan C, Zwacka RM, Engelhardt JF: Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med, 1999, 77, 577-596.
6. Hsu CM, Wang JS, Liu CH, Chen LW: Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock, 2002, 17, 280-285.
7. Imaeda A, Kaneko T, Aoki T, Kondo Y, Nakamura N, Nagase H, Yoshikawa T: Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice. Food Chem Toxicol, 2002, 40, 1415-1422.
8. Jasińska M, Owczarek J, Orszulak-Michalak D: Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep, 2007, 59, 483-499.
9. Johanson LH, Borg HLA: A spectrophotometric method for determination of catalase activity in small tissue sample. Anal Biochem, 1988, 174, 331-336.
10. Kakkis JL, Ke B, Dawson S, Maggard M, Si M, Kaldas F, Cai Wet al.: Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats. J Surg Res, 1997, 69, 393-398.
11. Koçak G, Aktan F, Canbolat O, Ozogul C, Elbeg S, Yildizoglu-Ari N, Karasu C: ADIC Study Group - Antioxidants in Diabetes-Induced Complications: Alphalipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab, 2000, 13, 308-318.
12. Kurzepa J, Bielewicz J, Bartosik-Psujek H, Szczepañska-Szerej A, Stelmasiak Z: Simvastatin inhibits the increase in serum tau protein levels in the acute phase of ischemic stroke. Pharmacol Rep, 2008, 60, 1014-118.
13. Laufs U, La Fata V, Liao JK: Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxiamediated down-regulation of endothelial nitric oxide synthase. J Biol Chem, 1997, 272, 31725-31729.
14. Lü P, Liu F, Wang CY, Chen DD, Yao Z, Tian Y, Zhang JH et al.: Gender differences in hepatic ischemic reperfusion injury in rats are associated with endothelial cell nitric oxide synthase-derived nitric oxide. World J Gastroenterol, 2005, 11, 3441-3445.
15. Morales AI, Vincente-Sanchez C, Jerkic M, Santiago JM, Sanchez-Gonzales PD, Perez-Barriocanal F, Lopez-Novoa JM: Effect of quercetin on metallothionein, nitric oxide synthase and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats. Toxicol Appl Pharmacol, 2006, 210, 128-135.
16. Ozansoy G, Akin B, Aktan F, Karasu Ç: Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. Mol Cell Biochem, 2001, 216, 59-63.
17. Parker RA, Huang Q, Tesfamariam B: Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature. Atherosclerosis, 2003, 169, 19-29.
18. Passi S, Stancato A, Aleo E, Dmitrieva A, Littarru GP: Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors, 2003, 18, 113-124.
19. Satoh K: Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta, 1978, 90, 37-43.
20. Scandalios JG: Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res, 2005, 38, 995-1014.
21. Serracino-Inglott F, Virlos IT, Habib NA, Williamson RCN, Mathie RT: Differential nitric oxide synthase expression during hepatic ischemia-reperfusion. Am J Surg, 2003, 185, 589-595.
22. Somuncu S, Cakmak M, Dikmen G, Akman H, Kaya M: Ischemia-reperfusion injury of rabbit ovary and protective effect of trapidil: an experimental study. Pediatr Surg Int, 2008, 24, 315-318.
23. Suzumura K, Yasuhara M, Narita H: Superoxide anion scavenging properties of fluvastatin and its metabolites. Chem Pharm Bull, 1999, 47, 1477-1480.
24. Talbert RL: Safety issues with statin therapy. J Am Pharm Assoc (2003), 2006, 46, 479-488.
25. Turgut F, Bayrak O, Catal F, Bayrak R, Atmaca AF, Koc A, Akbas A et al.: Antioxidant and protective effects of silymarin on ischemia and reperfusion injury in the kidney tissues of rats. Int Urol Nephrol, 2008, 40, 453-460.
26. Wassmann S, Nickenig G: Interrelationship of free oxygen radicals and endothelial dysfunction-modulation by statins. Endothelium, 2003, 10, 23-33.
27. Wassmann S, Wassmann K, Nickenig G: Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension, 2004, 44, 381-386.
28. Watanabe T, Yasunari K, Nakamura M: Antioxidative actions of statins: Potential mechanisms for antiathersclerotic effects. Mini Rev Med Chem, 2006, 6, 505-508.
29. Zhu B, Shen H, Zhou J, Lin F, Hu Y: Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection. Nephron Exp Nephrol, 2005, 101, e1-e8.
30. Zivna H, Zivny P, Palicka V, Simakova E: Influence of high cholesterol diet and pravastatin sodium on the initiation of liver regeneration in rats after partial hepatectomy. Nutrition, 2002, 18, 51-55.